2017 Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $19500

11:00 EDT 20 Jun 2017 | BioPortfolio Reports

Complete report $19,500. DataPack test volumes, sales forecasts, supplier shares $12,500.
The report is available by country, section, market segment, individual test, and can be customtailored to your specific information needs and budget.

This new sevencountry study from VPGMarketResearchnbsp;contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsnbsp;market during the next five years.

Report Highlights

Business and technological trends in major markets
Fiveyear test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Strategic profiles of leading market players and startup firms developing innovative products
Specific product and business opportunities for instrument and consumable suppliers.


The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of costeffective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage


Worldwide Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testingnbsp;for infectious diseases by country and market segment.

Fiveyear test volume and sales projections by country.

Market Segmentation Analysis

Sales and market shares of leading suppliers of infectious disease molecular diagnosticnbsp;reagent kits and components.

Fiveyear test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

A comprehensive analysis of the sequencing market by country and laboratory segment.

Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

Comparison of leading infectious disease molecular diagnosticnbsp;analyzers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

Worldwide listings of companies, universities and research centers developing new molecular diagnosticnbsp;technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in Ramp;D.

nbsp;nbsp; Abbott
nbsp;nbsp; Affymetrix
nbsp;nbsp; Agilent Technologies
nbsp;nbsp; Applied Gene Technologies
nbsp;nbsp; Arca Biopharma
nbsp;nbsp; Beckman Coulter/Danaher
nbsp;nbsp; Becton Dickinson
nbsp;nbsp; Biokit
nbsp;nbsp; BioMerieux
nbsp;nbsp; BioRad
nbsp;nbsp; Biotest
nbsp;nbsp; CellMark Forensics/LabCorp
nbsp;nbsp; Cepheid
nbsp;nbsp; DecodeGenetics
nbsp;nbsp; Diadexus
nbsp;nbsp; Eiken
nbsp;nbsp; Elitech Group
nbsp;nbsp; Enzo
nbsp;nbsp; Exact Sciences
nbsp;nbsp; Fujirebio
nbsp;nbsp; Grifols
nbsp;nbsp; Hologic/GenProbe
nbsp;nbsp; Illumina
nbsp;nbsp; Kreatech/Leica
nbsp;nbsp; LiCor Biosciences
nbsp;nbsp; Monogram Biosciences
nbsp;nbsp; Myriad Genetics
nbsp;nbsp; OrthoClinical Diagnostics
nbsp;nbsp; Perkin Elmer/Caliper Life Sciences
nbsp;nbsp; Proteome Sciences
nbsp;nbsp; Qiagen
nbsp;nbsp; Roche
nbsp;nbsp; Scienion
nbsp; nbsp; Sequenom
nbsp; nbsp; Shimadzu
nbsp; nbsp; Siemens
nbsp; nbsp; Sierra Molecular
nbsp; nbsp; Takara Bio
nbsp;nbsp; Tecan Group
nbsp; nbsp; Thermo Fisher

Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Contains 775 pages and 73 tables

Original Article: 2017 Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $19500


More From BioPortfolio on "2017 Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $19500"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...